Want to see USPH full AI Analyst Report?
USPH Stock Chart & Stats
$76.57
$0.25(0.28%)
At close: 4:00 PM EST
$76.57
$0.25(0.28%)
Day’s Range― - ―
52-Week Range$58.19 - $93.50
Previous CloseN/A
Volume11.83K
Average Volume (3M)211.53K
Market Cap
$1.12B
Enterprise Value$1.79K
Total Cash (Recent Filing)$28.44M
Total Debt (Recent Filing)$362.83M
Price to Earnings (P/E)147.1
Beta0.94
Next Earnings
Jul 30, 2026EPS Estimate
0.81Next Dividend Ex-DateN/A
Dividend Yield2.25%
Share Statistics
EPS (TTM)0.50
Shares Outstanding15,218,789
10 Day Avg. Volume217,016
30 Day Avg. Volume211,535
Financial Highlights & Ratios
PEG Ratio-2.41
Price to Book (P/B)2.49
Price to Sales (P/S)1.52
P/FCF Ratio19.43
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$92.67Price Target Upside21.02% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)2.9
Revenue Forecast (FY)$838.68M
Bulls Say, Bears Say
Bulls Say
Multi-year Revenue And Visit GrowthSustained top-line expansion and rising visit volumes indicate durable demand and successful clinic footprint and referral coverage expansion. Multi-year revenue growth supports long-term cash generation, scale benefits and provides a structural base to absorb investments in tech, partnerships and incremental margins.
Consistent Cash Generation And Positive FCFReliable operating cash flow and positive free cash flow provide a durable funding source for dividends, M&A, and reinvestment. Even with earnings volatility, consistent cash generation underpins capital allocation flexibility and reduces reliance on external financing over a multi-quarter horizon.
IIP Segment Momentum And Higher MarginsThe higher-growth, higher-margin industrial injury prevention business diversifies revenue and improves overall margin profile. Continued IIP expansion and the ability to scale employer contracts create a structural lever for sustainable margin improvement and recurring contracted revenue.
Bears Say
Material Margin And Return CompressionA pronounced decline in net margin and ROE signals deteriorating profitability and weaker capital efficiency. If margins remain compressed, earnings power and returns on invested capital are impaired, limiting the company's ability to sustainably fund dividends, buybacks or high-return investments over several quarters.
Rising Operating And Labor Costs Per VisitHigher payroll and operating costs per visit are directly eroding physical therapy margins. Given dependence on third-party reimbursement and limited immediate pricing leverage for some payors, persistent cost inflation could structurally limit margin recovery and reduce sensitivity of revenue growth to earnings.
Weaker Liquidity And Higher BorrowingsDeclining cash balances alongside increased borrowings reduce near-term liquidity and raise interest exposure. Higher leverage tied to acquisitions and partner purchases constrains financial flexibility and increases the importance of consistent cash flow and margin recovery to maintain investment and dividend policies.
US Physical Therapy News
USPH FAQ
What was U.s. Physical Therapy’s price range in the past 12 months?
U.s. Physical Therapy lowest stock price was $58.19 and its highest was $93.50 in the past 12 months.
What is U.s. Physical Therapy’s market cap?
U.s. Physical Therapy’s market cap is $1.12B.
When is U.s. Physical Therapy’s upcoming earnings report date?
U.s. Physical Therapy’s upcoming earnings report date is Jul 30, 2026 which is in 11 days.
How were U.s. Physical Therapy’s earnings last quarter?
U.s. Physical Therapy released its earnings results on May 06, 2026. The company reported $0.46 earnings per share for the quarter, missing the consensus estimate of $0.517 by -$0.057.
Is U.s. Physical Therapy overvalued?
According to Wall Street analysts U.s. Physical Therapy’s price is currently Undervalued.
Does U.s. Physical Therapy pay dividends?
U.s. Physical Therapy pays a Quarterly dividend of $0.46 which represents an annual dividend yield of 2.25%. See more information on U.s. Physical Therapy dividends here
What is U.s. Physical Therapy’s EPS estimate?
U.s. Physical Therapy’s EPS estimate is 0.81.
How many shares outstanding does U.s. Physical Therapy have?
U.s. Physical Therapy has 15,218,789 shares outstanding.
What happened to U.s. Physical Therapy’s price movement after its last earnings report?
U.s. Physical Therapy reported an EPS of $0.46 in its last earnings report, missing expectations of $0.517. Following the earnings report the stock price went down -19.891%.
Which hedge fund is a major shareholder of U.s. Physical Therapy?
Currently, no hedge funds are holding shares in USPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
US Physical Therapy Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$92.67 (21.02% Upside)
$92.67 (21.02% Upside)
Blogger Sentiment
Bearish
USPH Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 132.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 2.0%
Last 30 Days ▲ 2.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.62%
12-Months-Change
Fundamentals
Return on Equity
0.24%
Trailing 12-Months
Asset Growth
5.29%
Trailing 12-Months
Company Description
U.s. Physical Therapy
U.S. Physical Therapy, Inc., through its various subsidiaries, manages a network of outpatient physical therapy facilities. These clinics deliver a range of services, including rehabilitation before and after surgery, treatment for musculoskeletal conditions, recovery from sports-related trauma, proactive health measures, assistance for workers recovering from injuries, and care for neurological conditions. The company's business is divided into two primary divisions: Physical Therapy Operations and Industrial Injury Prevention Services. Within its industrial segment, it provides specialized services like on-site injury avoidance and recovery programs, strategies for enhancing physical performance, pre-employment screening tests, assessments of an individual's work capacity, and workplace ergonomic reviews. These offerings are delivered by licensed physical therapists and expert certified athletic trainers to a diverse clientele, including Fortune 500 corporations, insurance providers, and their associated contractors. By the end of 2021, specifically December 31st, the company had established 591 operational clinics across 39 states, in addition to overseeing 35 other physical therapy sites. Established in 1990, the company maintains its headquarters in Houston, Texas.
USPH Stock 12 Month Forecast
Average Price Target
$92.67
▲(21.02% Upside)
Technical Analysis
AMN Healthcare Services
―
Healthcare Services
―
Pediatrix Medical Group
―
―
Pennant Group
―
Ownership Overview
2.31% Insiders
29.05% Mutual Funds
5.68% Other Institutional Investors
36.17% Public Companies and
Individual Investors